At week 68, mean bodyweight change was 14.9% down with semaglutide and 2.4% down with placebo, an estimated treatment difference of 12.4 percentage points
Combining semaglutide with other peptides Some researchers stack semaglutide with other peptides that target complementary pathways
UK supply is restricted to in vitro and analytical research use only, not human administration
CJC 1295 is a synthetic peptide that you can administer to bring out growth hormone (GH) release from your pituitary gland
Losing 5 to 10% of body weight, even temporarily, provides health benefits, from improved blood sugar to reduced joint strain to better sleep
Possibly adding a new entrant to the highly competitive diabetes/weight loss market, Roche has announced positive interim results from an ongoing Phase I trial for its oral small molecule GLP-1 receptor agonist, CT996